Search Results - "Casinelli, K"

Immunosuppression-driven HBV reactivation in patients with resolved HBV infection correlates with a relevant risk of death and with evolution towards active chronical infection by Battisti, A, Salpini, R, Colagrossi, L, Alteri, C, Pollicita, M, Ricciardi, A, Cerva, C, Maffongelli, G, Lichtner, M, Mastroianni, C, Casinelli, K, Paoloni, M, Marignani, M, Maylin, S, Delaugerre, C, Morisco, F, Coppola, N, Marrone, A, Brega, A, Francioso, S, Venditti, A, Mari, T, Mazzoni, E, Iapadre, N, Di Paolo, D, Sarrecchia, C, Sarmati, L, Andreoni, M, Taliani, G, Angelico, M, Perno, C.F, Svicher, V

Get full text

Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies by Di Maio, Velia C., Cento, Valeria, Aragri, Marianna, Rossi, Piera, Verucchi, Gabriella, Magni, Carlo F., Teti, Elisabetta, Micheli, Valeria, Calvaruso, Vincenza, Gianserra, Laura, Romagnoli, Dante, Cozzolongo, Raffaele, Grieco, Antonio, Morisco, Filomena, Brancaccio, Giuseppina, Di Biagio, Antonio, Loggi, Elisabetta, Mastroianni, Claudio M., Pace Palitti, Valeria, Tarquini, Pierluigi, Puoti, Massimo, Vullo, Vincenzo, Paoloni, Maurizio, Pasquazzi, Caterina, Rizzardini, Giuliano, Parruti, Giustino, Craxì, Antonio, Babudieri, Sergio, Angelico, Mario, Ceccherini‐Silberstein, Francesca, Grimaldi, A., Verucchi, G., Menzaghi, B., Quirino, T., Torti, C., Vecchiet, J., Bruzzone, B., De Maria, A., Marenco, S., Viscoli, C., Lichtner, M., Aghemo, A., Boccaccio, V., Bruno, S., Cerrone, M., Colombo, M., Danieli, E., Donato, F., Gubertini, G., Lleo, A., Magni, C.F., Mancon, A., Monico, S., Gnocchi, M., Orro, A., Milanesi, L., Bertolotti, M., Borghi, V., Mussini, C., Gaeta, G.B., Sangiovanni, V., Di Marco, V., Mazzola, A., D'Amico, E., Cacciatore, P., Consorte, A., Pieri, A., Sozio, F., Baiocchi, L., Barbaliscia, S., Biliotti, E., Carioti, L., Cerasari, G., Cerva, C., Ciotti, M., D'Ettorre, G., De Leonardis, F., De Sanctis, A., Di Maio, V.C., Furlan, C., Gallo, P., Giannelli, V., Lattanzi, B., Lenci, I., Lula, R., Malagnino, V., Manuelli, M., Milana, M., Moretti, A., Palazzo, D., Pellicelli, A., Romano, M., Sarrecchia, C., Sorbo, M.C., Spaziante, M., Mangia, A., Maida, I., Mura, M.S., Falconi, L., Di Giammartino, D.

“…Background & Aims Despite the excellent efficacy of direct‐acting antivirals (DAA) reported in clinical trials, virological failures can occur, often…”
Get full text

HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV sub-genotypes 1 inducing different inflammatory stimuli by Salpini, R., Piermatteo, L., Torre, G., D'Anna, S., Khan, S., Duca, L., Bertoli, A., Malagnino, V., Paba, P., Ciotti, M., Lenci, I., Francioso, S., Paquazzi, C., Lichtner, M., Mastroianni, C., Santopaolo, F., De Sanctis, G., Marignani, M., Pellicelli, A., Galati, G., Moretti, A., Colucci, G., Casinelli, K., Caterini, L., Iapadre, N., Parruti, G., Vecchiet, I., Paoloni, M., Grelli, S., Ceccherini-Silberstein, F., Sarmati, L., Svicher, V.

“…In Italy, HDV-prevalence and its fluctuations over time are controversial while an extensive characterization of HDV-infected patients is missing. To assess…”
Get full text

Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study by Lanini, Simone, Scognamiglio, Paola, Mecozzi, Alessandra, Lombardozzi, Lorella, Vullo, Vincenzo, Angelico, Mario, Gasbarrini, Antonio, Taliani, Gloria, Attili, Adolfo Francesco, Perno, Carlo Federico, De Santis, Adriano, Puro, Vincenzo, Cerqua, Fabio, D'Offizi, Gianpiero, Pellicelli, Adriano, Armignacco, Orlando, Mennini, Francesco Saverio, Siciliano, Massimo, Girardi, Enrico, Panella, Vincenzo, Ippolito, Giuseppe

“…Management of chronic hepatitis C (CHC) has significantly accelerated in the last few years. Currently, second generation direct acting antivirals (DAAs)…”
Get full text

HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels by Di Maio, V C, Cento, V, Di Paolo, D, Aragri, M, De Leonardis, F, Tontodonati, M, Micheli, V, Bellocchi, M C, Antonucci, F P, Bertoli, A, Lenci, I, Milana, M, Gianserra, L, Melis, M, Di Biagio, A, Sarrecchia, C, Sarmati, L, Landonio, S, Francioso, S, Lambiase, L, Nicolini, L A, Marenco, S, Nosotti, L, Giannelli, V, Siciliano, M, Romagnoli, D, Pellicelli, A, Vecchiet, J, Magni, C F, Babudieri, S, Mura, M S, Taliani, G, Mastroianni, C, Vespasiani-Gentilucci, U, Romano, M, Morisco, F, Gasbarrini, A, Vullo, V, Bruno, S, Baiguera, C, Pasquazzi, C, Tisone, G, Picciotto, A, Andreoni, M, Parruti, G, Rizzardini, G, Angelico, M, Perno, C F, Ceccherini-Silberstein, F

“…This study aims to evaluate the reliability and clinical utility of NS3 sequencing in hepatitis C virus (HCV) 1-infected patients who were candidates to start…”
Get full text

A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon by Fattovich, Giovanna, Giustina, Giuliano, Favarato, Susanna, Ruol, Arturo

“…Aims: The aim of this study was to assess the incidence of fatal, life-threatening side effects and the de novo appearance of non-hepatic morbidity during…”
Get full text